Valeant Pharmaceuticals

Valeant Pharmaceuticals (VRX) Stock Will Rebound
  • Valeant Pharmaceuticals (VRX) Stock Will Rebound

Valeant Pharmaceuticals (VRX) Stock Will Rebound

By |June 20th, 2016|

Valeant Pharmaceuticals Intl Inc (NYSE: VRX)

Valeant Pharmaceuticals is possibly the most heavily debated stock in the biotechnology sector at the moment, and for good reason. The company was caught red-handed misleading investors. So, there’s plenty of fuel for the bearish fire. On the other hand, the bears argue that the company has made several […]

Valeant Pharmaceuticals (VRX) Stock: I Smell Opportunity
  • Valeant Pharmaceuticals (VRX) Stock: I Smell Opportunity

Valeant Pharmaceuticals (VRX) Stock: I Smell Opportunity

By |June 16th, 2016|

Valeant Pharmaceuticals Intl Inc (NYSE: VRX)

Valeant Pharmaceuticals has had an incredibly hard time in the market over the past several months, and for good reason. Late last year, the company was the subject of several major news stories talking about a scandal. However, since then, I believe that the stock has become a strong […]

Valeant Pharmaceuticals (VRX) Stock: Climbing on Takeover Rejection!
  • Valeant Pharmaceuticals (VRX) Stock: Climbing on Takeover Rejection!

Valeant Pharmaceuticals (VRX) Stock: Climbing on Takeover Rejection!

By |May 27th, 2016|

Valeant Pharmaceuticals Intl Inc (NYSE: VRX)

Valeant Pharmaceuticals is having an incredibly strong day in the market today, and for good reason. News surfaced that the company has made the decision to decline a joint takeover bid. Today, we’ll talk about the details of the bid, how the market reacted to the news, and what […]

Valeant Pharmaceuticals (VRX) Stock: Gaining Ahead of Earnings
  • Valeant Pharmaceuticals (VRX) Stock: Gaining Ahead of Earnings

Valeant Pharmaceuticals (VRX) Stock: Gaining Ahead of Earnings

By |May 17th, 2016|

Valeant Pharmaceuticals Intl Inc (NYSE: VRX)

Valeant Pharmaceuticals is having a strong day in the market today, signaling that investors are expecting to see an overwhelmingly positive report. This is a much needed sign of good news from VRX as the stock has been plummeting for months now. Today, we’ll talk about why Valeant Pharmaceuticals […]

Valeant Pharmaceuticals (VRX) Stock: The Bears Come Out to Play
  • Valeant Pharmaceuticals (VRX) Stock: The Bears Come Out to Play

Valeant Pharmaceuticals (VRX) Stock: The Bears Come Out to Play

By |April 22nd, 2016|

Valeant Pharmaceuticals Intl Inc (NYSE: VRX)

Valeant Pharmaceuticals is having a great day in the market. However, for many the recent upswing we’ve seen in the stock is a shocker. After all, VRX has been falling for quite some time. Today, we’ll talk about why the stock has had such a rough time in the […]

Valeant Pharmaceuticals (VRX) Stock: a Race Against a Default
  • Valeant Pharmaceuticals (VRX) Stock: a Race Against a Default

Valeant Pharmaceuticals (VRX) Stock: a Race Against a Default

By |April 13th, 2016|

Valeant Pharmaceuticals Intl Inc (NYSE: VRX)

Valeant Pharmaceuticals is having an incredibly rough time in the market, and it has been for some time. Ever since Citron published a report calling the company the Enron of the pharmaceutical industry, the stock has tanked. Now, it seems as though things have gone from bad to worse […]

Valeant Pharmaceuticals (VRX) Stock: Time to Buy?
  • Valeant Pharmaceuticals (VRX) Stock: Time to Buy?

Valeant Pharmaceuticals (VRX) Stock: Time to Buy?

By |April 1st, 2016|

Valeant Pharmaceuticals Intl Inc (NYSE: VRX)

Valeant Pharmaceuticals is a company that has dealt with quite a few hurdles as of late. Unfortunately, the company has seen its stock fall dramatically over the past several months, and analysts continue to expect further downward movement. However, with everything we’ve seen from VRX since the Philidor scandal, […]

Valeant Pharmaceuticals (VRX) Stock Tanks on Earnings
  • Valeant Pharmaceuticals (VRX) Stock Tanks on Earnings

Valeant Pharmaceuticals (VRX) Stock Tanks on Earnings

By |March 15th, 2016|

Valeant Pharmaceuticals Intl Inc (NYSE: VRX)

Valeant Pharmaceuticals is having a rough day in the market today, and for a very good reason. As I predicted in a post about VRX yesterday, the company has reported preliminary fourth quarter earnings, missing expectations in a big way. The company also provided relatively weak first quarter guidance. […]

Valeant Pharmaceuticals (VRX) Stock: More Declines to Come
  • Valeant Pharmaceuticals (VRX) Stock: More Declines to Come

Valeant Pharmaceuticals (VRX) Stock: More Declines to Come

By |March 5th, 2016|

Valeant Pharmaceuticals Intl Inc (NYSE: VRX)

Valeant Pharmaceuticals has had a rough time over the past several months, and for good reason. A few months ago, there were big concerns among investors with regard to the relationship between Valeant Pharmaceuticals and a pharmacy known as Philidor. Since then, there has been some good and some […]

Valeant Pharmaceuticals (VRX) Stock: Declines on CEO Troubles
  • Valeant Pharmaceuticals (VRX) Stock: Declines on CEO Troubles

Valeant Pharmaceuticals (VRX) Stock: Declines on CEO Troubles

By |December 28th, 2015|

Valeant Pharmaceuticals Intl Inc (NYSE: VRX)

Valeant Pharmaceuticals has been on a bit of a roller coaster ride in the market as of late, and unfortunately, the roller coaster is currently pointing downward. After confirmation that J. Michael Pearson, the CEO and Chairman of the board at VRX is currently on medical leave, the stock […]